| 2022-11-17 | Ardelyx, Inc. ARDX | director | 567,000 0.3666% | $1.76 | $1M | +112.21% | ||
| 2021-09-23 | Sale | Novavax, Inc. NVAX | director | 24,961 0.0328% | $252.90 | $6.31M | -71.35% | |
| 2020-12-10 | Ardelyx, Inc. ARDX | director | 170,000 0.1864% | $5.89 | $1M | +13.86% | ||
| 2020-06-25 | Ardelyx, Inc. ARDX | director | 68,373 0.0772% | $6.96 | $476,040 | -3.97% | ||
| 2020-06-24 | Ardelyx, Inc. ARDX | director | 72,598 0.0821% | $6.75 | $489,862 | -0.82% | ||
| 2020-06-22 | Ardelyx, Inc. ARDX | director | 4,673 0.005% | $6.75 | $31,525 | -6.67% | ||
| 2020-04-07 | Mersana Therapeutics, Inc. MRSN | director | 1.08M 1.2807% | $5.59 | $6.02M | +153.23% | ||
| 2020-01-24 | Adaptimmune Therapeutics plc ADAP | 7.5M 1.0346% | $0.67 | $5M | +34.69% | |||
| 2019-07-22 | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 900,000 2.6907% | $7.50 | $6.75M | +5.09% | ||
| 2019-05-09 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 5M 34.6117% | $10.00 | $50M | -42.9% | ||
| 2019-05-07 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 1.14M 6.1239% | $1.08 | $1.23M | -40% | ||
| 2019-03-05 | Mersana Therapeutics, Inc. MRSN | 7.5M 23.242% | $4.00 | $30M | -3.05% | |||
| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | 30M 4.8721% | $1.67 | $50M | -57.66% | |||
| 2018-03-27 | Adaptimmune Therapeutics plc ADAP | 12M 2.1988% | $1.92 | $23M | -12.28% | |||
| 2018-03-27 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 707,964 4.6641% | $2.70 | $1.91M | -8.89% | ||
| 2018-03-26 | Adaptimmune Therapeutics plc ADAP | 1.14M 0.2007% | $1.90 | $2.18M | -14.01% | |||
| 2018-03-23 | Adaptimmune Therapeutics plc ADAP | 588,180 0.1062% | $1.95 | $1.14M | -12.52% | |||
| 2018-03-22 | Adaptimmune Therapeutics plc ADAP | 1.74M 0.308% | $1.90 | $3.31M | -12.12% | |||
| 2018-03-21 | Adaptimmune Therapeutics plc ADAP | 209,688 0.0355% | $1.81 | $379,640 | -10.61% | |||
| 2018-02-26 | Sale | ARCA biopharma, Inc. ABIO | 10 percent owner | 1.46M 11.9306% | $0.50 | $731,273 | +22.22% |